Despite an evident trend in the increased WAM of AACT across four-time points observed in all patients, we observed significant differences in glycoproteoform profiles between the different patients, which indicated that the T1 baseline glycoproteoform profile for each patient is already quite different.
← all excerpts
Glycoproteoform Profiles of Individual Patients' Plasma Alpha-1-Antichymotrypsin are Unique and Extensively Remodeled Following a Septic Episode.
1
—
—